Evidence map›Paper›PMID 28854255›Full record

ArticlePloS one2017

Protein abundances can distinguish between naturally-occurring and laboratory strains of Yersinia pestis, the causative agent of plague.

Eric D Merkley, Landon H Sego, Andy Lin, Owen P Leiser, Brooke L Deatherage Kaiser, Joshua N Adkins, Paul S Keim, David M Wagner, Helen W Kreuzer

Abstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Eric D MerkleyChemical and Biological Signature Sciences, Pacific Northwest National Laboratory, Richland, Washington, United States of America.
Landon H SegoApplied Statistics and Computational Modeling, Pacific Northwest National Laboratory, Richland, Washington, United States of America.
Andy LinChemical and Biological Signature Sciences, Pacific Northwest National Laboratory, Richland, Washington, United States of America.ORCID http://orcid.org/0000-0003-0072-612X
Owen P LeiserPathogen and Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, United States of America.
Brooke L Deatherage KaiserChemical and Biological Signature Sciences, Pacific Northwest National Laboratory, Richland, Washington, United States of America.
Joshua N AdkinsBiological Sciences Division, Pacific Northwest National Laboratory, Richland, Washington, United States of America.
Paul S KeimPathogen and Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, United States of America.
David M WagnerPathogen and Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, United States of America.
Helen W KreuzerChemical and Biological Signature Sciences, Pacific Northwest National Laboratory, Richland, Washington, United States of America.

Funding

Consortia for High-Throughput-Enabled Structural Biology Partnerships (U01)U01GM094623 · NIGMS · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI ADKINS, JOSHUA N. · 2010 to 2014
$5.2M
SURFACE CHEMISTRY OF MYCOBACTERIAR01AI008401 · NIAID · NATIONAL JEWISH HEALTH · PI GOREN, MAYER B. · 1989 to 1989
–
SURFACE CHEMISTRY OF MYCOBACTERIAR22AI008401 · NIAID · NATIONAL JEWISH HEALTH · PI GOREN, MAYER B. · 1985 to 1989
–
NIAID NIH HHS Y01 AI008401NIGMS NIH HHS U01 GM094623
6 · The paper itself

Abstract

The rapid pace of bacterial evolution enables organisms to adapt to the laboratory environment with repeated passage and thus diverge from naturally-occurring environmental ("wild") strains. Distinguishing wild and laboratory strains is clearly important for biodefense and bioforensics; however, DNA sequence data alone has thus far not provided a clear signature, perhaps due to lack of understanding of how diverse genome changes lead to convergent phenotypes, difficulty in detecting certain types of mutations, or perhaps because some adaptive modifications are epigenetic. Monitoring protein abundance, a molecular measure of phenotype, can overcome some of these difficulties. We have assembled a collection of Yersinia pestis proteomics datasets from our own published and unpublished work, and from a proteomics data archive, and demonstrated that protein abundance data can clearly distinguish laboratory-adapted from wild. We developed a lasso logistic regression classifier that uses binary (presence/absence) or quantitative protein abundance measures to predict whether a sample is laboratory-adapted or wild that proved to be ~98% accurate, as judged by replicated 10-fold cross-validation. Protein features selected by the classifier accord well with our previous study of laboratory adaptation in Y. pestis. The input data was derived from a variety of unrelated experiments and contained significant confounding variables. We show that the classifier is robust with respect to these variables. The methodology is able to discover signatures for laboratory facility and culture medium that are largely independent of the signature of laboratory adaptation. Going beyond our previous laboratory evolution study, this work suggests that proteomic differences between laboratory-adapted and wild Y. pestis are general, potentially pointing to a process that could apply to other species as well. Additionally, we show that proteomics datasets (even archived data collected for different purposes) contain the information necessary to distinguish wild and laboratory samples. This work has clear applications in biomarker detection as well as biodefense.

Indexed as

Adaptation, PhysiologicalBacterial ProteinsBacteriological TechniquesEnvironmental MicrobiologyHumansLogistic ModelsPhenotypePlagueProteomeProteomicsSpecies SpecificityYersinia pestisBacterial ProteinsProteome

Identifiers

PMID28854255
PMCPMC5576697

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.